FysioDanmark Helsinge ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.5% 11.3% 7.7% 2.3% 17.1%  
Credit score (0-100)  64 21 30 64 9  
Credit rating  BBB BB BB BBB BB  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  3,321 2,673 2,700 3,606 3,538  
EBITDA  865 -708 463 883 761  
EBIT  613 -1,043 179 653 537  
Pre-tax profit (PTP)  476.1 -1,178.2 145.5 629.0 -965.6  
Net earnings  386.7 -1,086.5 111.0 409.0 -1,075.2  
Pre-tax profit without non-rec. items  476 -1,178 145 629 -966  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,267 748 713 482 270  
Shareholders equity total  331 -196 -84.8 324 -751  
Interest-bearing liabilities  2,639 1,044 653 1,158 1,447  
Balance sheet total (assets)  3,850 1,659 1,334 2,095 2,751  

Net Debt  2,639 918 653 1,158 1,447  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,321 2,673 2,700 3,606 3,538  
Gross profit growth  -1.7% -19.5% 1.0% 33.6% -1.9%  
Employees  0 0 0 7 7  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,850 1,659 1,334 2,095 2,751  
Balance sheet change%  -26.8% -56.9% -19.6% 57.1% 31.3%  
Added value  613.3 -1,042.8 179.0 653.0 537.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -376 -2,994 -389 -461 -436  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  18.5% -39.0% 6.6% 18.1% 15.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  13.5% -36.6% 10.9% 37.2% 70.6%  
ROI %  15.8% -51.9% 21.1% 61.2% -60.2%  
ROE %  55.7% -109.2% 7.4% 49.3% -69.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  8.6% -10.6% -6.0% 15.5% -21.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  305.0% -129.6% 141.1% 131.1% 190.2%  
Gearing %  798.4% -533.4% -770.9% 357.4% -192.7%  
Net interest  0 0 0 0 0  
Financing costs %  4.3% 7.4% 3.9% 2.6% 6.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 0.4 0.3 0.2 0.7  
Current Ratio  0.2 0.4 0.4 0.2 0.7  
Cash and cash equivalent  0.0 126.4 0.0 0.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,070.4 -1,084.6 -869.1 -1,355.0 -1,092.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 93 77  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 126 109  
EBIT / employee  0 0 0 93 77  
Net earnings / employee  0 0 0 58 -154